EdenRoc Sciences is a life sciences portfolio company, focused on addressing the diseases of aging, with assets ranging from industry leading genomic detection to clinical stage pharmaceuticals, forensics and biologic-based consumer products.

EdenRoc has founded its subsidiaries based on novel science, often in the form of intellectual property licensed from top universities. The subsidiaries operate as autonomous companies with their own leadership and objectives.

Each is aided by a small group of personnel at the parent (EdenRoc) level, who support core business functions including legal, human resources, benefits, accounting, finance, IT, and business planning. Additionally, each subsidiary is aided by the resources and collaboration of the other subsidiaries.

This cross-fertilization is fostered by shared board oversight and the fact that employees and advisors are granted equity at the EdenRoc level. The result is a cooperative group of start-ups, each working for the benefit of all. 

Core to EdenRoc is the creation of an engine for developing leading technologies and skills which address multiple biotech and healthcare markets. From gold-standard diagnostic tools to novel therapeutics, EdenRoc is driven by a team of over one 100 brilliant scientists and other staff, with support from over 40 world-class advisors.